HIGHLIGHTS
- who: Cedric Brackenier and collaborators from the Department of Gastro-Enterology and Hepatology, University Hospitals, have published the article: Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma, in the Journal: Cancers 2023, 15, x FOR PEER REVIEW of 24/Oct/2022
- what: The main reason for this must be sought in the poor activity of systemically administered cytotoxic chemotherapeutics in this cancer type . For the purpose of this review, the authors will focus on their antiangiogenic properties. This study demonstrated an increase in OS of 1.2 months compared to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.